Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

Published:2019-10-14 Issue:4 Volume:71 Page:1247-1261
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Shigeta Kohei¹²,Datta Meenal¹,Hato Tai¹³,Kitahara Shuji¹⁴,Chen Ivy X.¹,Matsui Aya¹,Kikuchi Hiroto¹^ORCID,Mamessier Emilie¹⁵,Aoki Shuichi¹⁶,Ramjiawan Rakesh R.¹⁷,Ochiai Hiroki¹⁸,Bardeesy Nabeel⁹,Huang Peigen¹,Cobbold Mark⁹,Zhu Andrew X.⁹,Jain Rakesh K.¹,Duda Dan G.¹^ORCID

Affiliation:

1. Edwin. L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology Massachusetts General Hospital Boston MA

2. Department of Surgery Keio University School of Medicine Tokyo Japan

3. Department of Thoracic Surgery Saitama Medical Center Saitama Japan

4. Department of Anatomy and Developmental Biology Tokyo Women’s Medical University Tokyo Japan

5. Department of Molecular Oncology Cancer Research Center Marseille France

6. Department of Surgery Tohoku University Graduate School of Medicine Miyagi Japan

7. Angiogenesis Laboratory, Cancer Center Amsterdam, Department of Medical Oncology VU University Medical Center Amsterdam The Netherlands

8. Department of Surgery National Cancer Institute Central Hospital Tokyo Japan

9. Department of Medicine Massachusetts General Hospital MA

Funder

Uehara Memorial Foundation